아시아태평양의 업스트림 바이오프로세스 시장 예측(-2030년) : 지역 분석 - 제품 유형별, 워크플로우별, 용도별, 모드별

The Asia Pacific upstream bioprocessing market was valued at US$ 1,976.10 million in 2022 and is expected to reach US$ 5,678.99 million by 2030; it is estimated to grow at a CAGR of 14.1% from 2022 to 2030.

Technological Advancements Boost Asia Pacific Upstream Bioprocessing Market.

The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production.

Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, in turn, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring is revolutionizing data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, thereby unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability.

Asia Pacific Upstream Bioprocessing Market Overview

The Asia Pacific upstream bioprocessing market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the highest CAGR during 2022-2030. China, India, and Japan are three major contributors to the growth of the market in Asia Pacific, which is mainly driven by rising demand for bioreactors as well as an increase in research centers and government funding. Moreover, many international market players are focusing on countries in Asia Pacific for geographic expansion and other strategies.

Asia Pacific Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Upstream Bioprocessing Market Segmentation

The Asia Pacific upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Asia Pacific upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Asia Pacific upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Asia Pacific upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022.

Based on mode, the Asia Pacific upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Asia Pacific upstream bioprocessing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Asia Pacific upstream bioprocessing market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Upstream Bioprocessing Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Asia Pacific Upstream Bioprocessing Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Commercial Use of Single-Use Bioreactors
  • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
  • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
• 5.2 Market Restraints
  • 5.2.1 Stringent Regulatory Framework
• 5.3 Market Opportunities
  • 5.3.1 Technological Advancements
• 5.4 Future Trends
  • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
• 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Asia Pacific Analysis

7. Asia Pacific Upstream Bioprocessing Market Analysis - by Product Type

• 7.1 Bioreactors/Fermenters
  • 7.1.1 Overview
  • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 7.2 Cell Culture
  • 7.2.1 Overview
  • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 7.3 Filters
  • 7.3.1 Overview
  • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Bags and Containers
  • 7.4.1 Overview
  • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Upstream Bioprocessing Market Analysis - by Workflow

• 8.1 Media Preparation
  • 8.1.1 Overview
  • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 8.2 Cell Culture
  • 8.2.1 Overview
  • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 8.3 Cell Separation
  • 8.3.1 Overview
  • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Upstream Bioprocessing Market Analysis - by Usage Type

• 9.1 Single-use
  • 9.1.1 Overview
  • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 9.2 Multi-use
  • 9.2.1 Overview
  • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Upstream Bioprocessing Market Analysis - by Mode

• 10.1 In-house
  • 10.1.1 Overview
  • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
• 10.2 Outsourced
  • 10.2.1 Overview
  • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Upstream Bioprocessing Market - Country Analysis

• 11.1 Asia Pacific Market Overview
  • 11.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
    • 11.1.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
    • 11.1.1.2 China
    • 11.1.1.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode
    • 11.1.1.4 Japan
    • 11.1.1.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode
    • 11.1.1.6 India
    • 11.1.1.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode
    • 11.1.1.8 Australia
    • 11.1.1.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode
    • 11.1.1.10 South Korea
    • 11.1.1.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode
    • 11.1.1.12 Rest of Asia Pacific
    • 11.1.1.13 Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.13.1 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Product Type
      • 11.1.1.13.2 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Workflow
      • 11.1.1.13.3 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Usage Type
      • 11.1.1.13.4 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in Upstream Bioprocessing Market
• 12.3 Organic Growth Strategies
  • 12.3.1 Overview
• 12.4 Inorganic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Thermo Fisher Scientific Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Esco Micro Pte Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Sartorius AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Danaher Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Getinge AB
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Merck KGaA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Corning Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 Entegris Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms